Status:

UNKNOWN

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial)

Lead Sponsor:

Medical University of Vienna

Conditions:

Peripheral Arterial Disease

Eligibility:

All Genders

50-90 years

Phase:

PHASE2

PHASE3

Brief Summary

Prospective monocenter single-blind randomized (1:1) investigator sponsored clinical trial, in which consecutive patients candidates for percutaneous intervention of angioplasty to treat symptomatic i...

Detailed Description

Introduction Restenosis after endovascular stenting with nitinol stents occurs in up to 30% of the patients at 12 months and up to 50% at 24 months. The rate of recurrence after repeated treatment of...

Eligibility Criteria

Inclusion

  • All criteria 1-6 should apply for inclusion.
  • Age \> 50 years
  • Patient legally authorized to provide written informed consent
  • Patient willing and likely to comply with the follow up schedule
  • Patient symptomatic Rutherford-Becker 2-5 (Fontaine II-IV)
  • In-stent restenosis in the SFA and P1 segment of the popliteal artery (PA)
  • Tibial run-off of at least 1 artery which however may be stenotic but amenable to PTA

Exclusion

  • Patients unable to give informed consent
  • Patients enrolled in another study with any investigational drug or device
  • Major surgical procedures (not including minor amputations) within 30 days prior to this study or planned within 30 days of entry into this study
  • Pregnancy
  • Patients with any known allergy, hypersensitivity or intolerance to radiologic contrast media, ASA, Clopidogrel or Ticlopidine, Paclitaxel
  • Life expectancy of \< 1 years

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2012

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01247402

Start Date

November 1 2010

End Date

December 1 2012

Last Update

December 9 2010

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Angiology

Vienna, Vienna, Austria, 1090

2

Cardiovascular and Interventional Radiology, AKH-MUW

Vienna, Vienna, Austria, 1090